Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005

Journal of Family Practice

Volumn 54, Issue SUPPL. 1, 2005, Pages

  Zimmerman, Richard Kent ^a,b   Middleton, Donald B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; PALIVIZUMAB; PNEUMOCOCCUS VACCINE; RABIES VACCINE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RUBELLA VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VACCINE; YELLOW FEVER VACCINE;

ANAPHYLAXIS; ASPLENIA; ASTHMA; CHICKENPOX; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; EDUCATION PROGRAM; FEVER; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEART DISEASE; HEPATITIS A; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HYPOTENSION; INFLUENZA; INJECTION PAIN; LIFESTYLE; MEASLES; MORBIDITY; MORTALITY; NURSING HOME; OCCUPATIONAL HAZARD; PRACTICE GUIDELINE; PREGNANCY; PREMATURITY; RABIES; RASH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SIDE EFFECT; STREPTOCOCCUS INFECTION; TRAVEL; VACCINATION; VETERINARY MEDICINE; VIRUS INFECTION;

BACTERIAL VACCINES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOCOMPROMISED HOST; INFLUENZA, HUMAN; MALE; OCCUPATIONAL DISEASES; PNEUMOCOCCAL INFECTIONS; PREGNANCY; RISK FACTORS; VIRAL VACCINES;

EID: 12144253820     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45:1-36.
2. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1-38.
3. Meissner HC, Long SS. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1447-1452.
4. American Academy of Pediatrics. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442-1446.
5. Pickering LD, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2003.
6. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Recomm Rep. 1993;42:1-18.
7. Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients [published correction appears in MMWR Recomm Rep. 2004;53:396]: MMWR Recomm Rep. 2000;49:1-125.
8. Centers for Disease Control and Prevention. Notice to readers: revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Aforb Mortal Wkly Rep. 2001;50:1117.
9. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardio pulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094-1102.
10. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53:1-40.
11. Woods CR, Rosenstein N, Perkins BA. Neisseria meningitidis outbreaks in the United States, 1994-97. In: Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America; November 12-15, 1998; Denver, Colo.
12. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students [published correction appears in JAMA. 2000;283:2659]. JAMA. 1999;281:1906-1910.
13. Potter J, Stott DJ, Elder AG, O'Donnell B, Knight PV, Carman WF. Influenza vaccination of health care workers in long-term care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1-6.
14. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-97.
15. Gibas A, Blewett K, Schoenfeld DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol. 1992;136:603-610.
16. Occupational Safety and Health Administration. Bloodborne Pathogens and Acute Care Facilities. Washington, DC: US Department of Labor, Occupational Safety and Health Administration; 1995.
17. Centers for Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers [published correction appears in MMWR Morb Mortal Wkly Rep. 1989;38:746]. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 6):1-37.
18. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001;50:1-42.
19. Centers for Disease Control and Prevention. Human rabies prevention - United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 1999;48:16 and MMWR Morb Mortal Wkly Rep. 2000;49:737]. MMWR Recomm Rep. 1999;48:1-21.
20. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263:1218-1222.
21. Centers for Disease Control and Prevention. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1993;42:1-15.
22. Centers for Disease Control and Prevention. Health Information for International Travel 2003-2004. Atlanta, Ga: US Department of Health and Human Services, Public Health Service; 2003.